Therapeutics Ocumension serves as Executive at EyePoint Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Therapeutics Ocumension has executed 3 insider transactions totaling $56.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 11, 2024 involved selling 1,910,500 shares valued at $37.2M.
Therapeutics Ocumension currently holds 100,221 shares of EyePoint Pharmaceuticals, Inc. (EYEP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Therapeutics Ocumension has been a net seller of EYEP stock. They have purchased $0 and sold $56.7M worth of shares.
Therapeutics Ocumension's most recent insider trade was on Jan 11, 2024, when they sold 1,910,500 shares at $19.45 per share.
Get notified when new Form 4 filings are submitted
| $18.41 |
| Discretionary |
| Dec 5, 2023 | EYEP | $14.6M | Sale | 733,758 | $19.91 | Discretionary |